Class Action Filed Against Zenas BioPharma, Inc. (ZBIO) Over Securities Violations - Contact Levi & Korsinsky Today

  • NEW YORK, NY / ACCESS Newswire / May 17, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=148996&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.